I never imagined I would be writing this. My mum passed away, and I don’t yet have the words to describe the emptiness she’s left behind. She wasn’t just my mother — she was my best friend, my anchor, my reason for fighting, and the heart behind everything we built here. This community was created for her. She carried more than most people ever see. She lived with bipolar disorder. She carried childhood trauma. She endured a painful divorce, the loss of both her parents, a cancer diagnosis, the death of Pepper — our family boxer — and the loss of Albert, our family’s closest friend. All of this happened within the last seven years. And yet — she kept going. She walked at least 10,000 steps a day. She swam three times a week. She went to church every Sunday. She worked tirelessly on the house. She quit smoking after her diagnosis. She tried carnivore. She cut out sugar. And most importantly: She kept our family together. She fought. She cared. She loved. Even when depression weighed heavily on her will to live, she chose to fight — not because it was easy, but because she loved us. She fought for us when her mind told her to give up. That is courage. We were hopeful. So hopeful. She had just started the Astron Health protocol — only one week in — and we believed we had time. Previous scans had been relatively reassuring, showing stable, very slow-growing, localised disease in the peritoneum and a coeliac lymph node, with no organ spread. Her CRP was 4 — within the normal range. Then everything changed — fast. She developed sudden, severe gastrointestinal pain, vomiting, and diarrhoea. We rushed to the hospital. A CT scan showed ischemic colitis. A mouth swab also confirmed COVID. She was put on palliative care, given fluids and heparin. Her circulation improved. Lactate came down. Symptoms improved. Objectively, things were getting better. But the narrative never changed. Despite improving vitals, improving markers, and improving symptoms, they continued to insist on bowel necrosis — even when the evidence did not clearly support it. At the same time, her CRP (an inflammation marker) rose rapidly from 4 (normal) just weeks earlier, to 14 on admission, to 150 the following day, and eventually to 455 at its peak. She developed rising oxygen requirements, hypoxia, and what appeared to be a clear systemic inflammatory storm — yet COVID pneumonitis was repeatedly dismissed.

I wanted to share something important with you — not as medical advice, but as part of our learning journey together ❤️ This post is shared for transparency and education only, not to suggest or recommend anything medically. This protocol was designed privately for my mum by Astron Health and is shared here purely for learning and discussion within our community. ✅ Everyone’s biology, cancer type, treatments, and risks are different ✅ Always work alongside your medical team My mum’s current protocol was built/personalised using molecular testing from her blood, done through Astron Health, who work with Exacta360. This kind of testing doesn’t just look at cancer type. It looks at what pathways are active, what the cancer appears to rely on, and what biological signals are dominant. In simple terms — it doesn’t ask: “What cancer is this?” It asks: “What is this cancer doing?” That shift changes everything. ✅ What This Kind of Testing Looks At From a simple blood sample, the analysis can look at things like: • inflammation signaling • growth and survival pathways • angiogenesis (blood vessel formation) • immune suppression markers • estrogen and hormone metabolism • metabolic stress pathways • mitochondrial vulnerability It gives a much clearer picture of the terrain. ✅ Something That Really Stood Out to Me What surprised me most was this… Almost everything Astron included was already part of our existing protocol. The core metabolic approach we’ve been using aligned very closely with what the molecular testing came back with — thanks in huge part to this community, Dr. Seyfried, and Jane McLelland. They added a few additional layers — such as: • atorvastatin • indole-3-carbinol • luteolin • apigenin • ursolic acid • propranolol But the foundation was already there. That was incredibly validating — not just emotionally, but scientifically. It confirmed that targeting the right pathways truly matters. ✅ Compounds That Came Up in Her Results Some of the natural compounds included were:

Does anyone here have any experience with this? I just purchased it and a 660nm red light.

https://www.facebook.com/share/p/1CU1QfHe5u/ Johns Hopkins’ New Mebendazole Patent and Its Significance for Cancer Therapeutics A recent public news article has highlighted a development that deserves serious attention within oncology and drug-repurposing research: Johns Hopkins scientists have patented a new crystalline form of mebendazole—referred to as polymorph C—designed to enhance its anti-cancer properties. Background: Why Mebendazole Matters Mebendazole is a benzimidazole-class anthelmintic with a well-characterised safety profile accumulated over ~40 years of clinical use. Beyond its antiparasitic activity, numerous preclinical studies have demonstrated: Microtubule inhibition in cancer cells Disruption of glucose metabolism in malignant tissues Interference with multiple signalling pathways (Hh, Wnt/β-catenin, Bcl-2) Selective cytotoxicity to tumour cells at concentrations tolerated by normal cells Despite these properties, clinical adoption has been limited largely because the original molecule is off-patent, making large-scale commercial trials financially unviable. What Johns Hopkins Has Patented The new patent centers on: Polymorph C — a redesigned crystalline form This form appears to demonstrate: Improved oral absorption Higher plasma concentrations Prolonged systemic exposure Greater potency in killing cancer cells in vitro compared with existing polymorphs This is scientifically notable, because mebendazole traditionally suffers from: Poor gastrointestinal absorption High inter-individual variability Low bioavailability unless taken with high-fat meals A more bioavailable crystalline form directly addresses these limitations. Synergy Through Transporter Inhibition The Johns Hopkins team also referenced co-administration with elacridar, a potent inhibitor of: P-glycoprotein (P-gp) Breast Cancer Resistance Protein (BCRP) These efflux pumps are responsible for removing chemotherapeutic agents from cancer cells.

Mebendazole....Anyone using this? Looking for a dose chart please.